Aripiprazole augmentation for somatic symptoms of depressio
Not Applicable
Recruiting
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0004607
- Lead Sponsor
- Chung-Ang Univerisity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
? Age between 20 and 65 years old
? Patients diagnosed with major depressive disorder not accompanied by psychotic symptoms by Structured Clinical Interview for DSM-5 (SCID-5)
? 11 or more points on the SCL-90R-SOM scale, meaning accompanying significant somatic symptoms.
? Those who have no history of using antipsychotics, including aripiprazole, at the time of initial evaluation
? Those who are taking antidepressants at stable dose for more than 1 month
Exclusion Criteria
? Those who have been diagnosed with other psychiatric disorder by SCID-5-CV
? People with past or present substance dependence or abuse history
? A person with a history of epilepsy, head trauma, or organic mental illness
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom Check List-90-Revised-Somatization (SCL-90-R-SOM)
- Secondary Outcome Measures
Name Time Method 1) Theta coherence of Quantitative Electroencephalogram (QEEG)